Henry Schein, Inc. (NASDAQ:HSIC – Free Report) shares have received a consensus rating of “Moderate Buy” from the twelve research firms that are currently covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation, five have issued a hold recommendation, five have issued a buy recommendation and one has issued a strong buy recommendation for the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is $77.10.
HSIC has been the subject of several research analyst reports. Evercore ISI lowered their price target on shares of Henry Schein from $72.00 to $70.00 and gave the company an “in-line” rating in a research report on Wednesday, August 7th. Barrington Research lowered their price target on shares of Henry Schein from $92.00 to $82.00 and gave the company an “outperform” rating in a research report on Wednesday, August 7th. JPMorgan Chase & Co. lowered their price target on shares of Henry Schein from $88.00 to $80.00 and gave the company an “overweight” rating in a research report on Monday. Piper Sandler reiterated an “overweight” rating and gave the company a $86.00 price target in a research report on Friday, June 21st. Finally, UBS Group lowered their price target on shares of Henry Schein from $75.00 to $72.00 and gave the company a “neutral” rating in a report on Wednesday, August 7.
Get our latest stock analysis on Henry Schein
Henry Schein share price development
HSIC opened at $69.44 on Wednesday. The company has a market cap of $8.89 billion, a price-to-earnings ratio of 23.46, a PEG ratio of 1.80 and a beta of 0.87. The company has a quick ratio of 1.02, a current ratio of 1.75 and a debt-to-equity ratio of 0.47. The company has a 50-day moving average price of $67.69 and a 200-day moving average price of $71.46. Henry Schein has a twelve-month low of $60.01 and a twelve-month high of $82.63.
Henry Schein (NASDAQ:HSIC – Get Free Report) last released its quarterly earnings results on Tuesday, August 6. The company reported earnings per share of $1.23 for the quarter, beating analysts’ consensus estimates of $1.22 by $0.01. Henry Schein had a net margin of 3.12% and a return on equity of 13.51%. The company had revenue of $3.10 billion for the quarter, compared to analyst estimates of $3.27 billion. During the same period last year, the company generated earnings per share of $1.31. Henry Schein’s revenue increased 0.0% compared to the same quarter last year. Equities analysts expect Henry Schein to report earnings per share of $5.16 for the current year.
Institutional trading by Henry Schein
A number of hedge funds and other institutional investors have recently made changes to their holdings in the company. Summit Trail Advisors LLC increased its stake in Henry Schein by 20.0% in the 2nd quarter. Summit Trail Advisors LLC now owns 10,271 shares of the company’s stock valued at $658,000 after acquiring an additional 1,709 shares during the last quarter. Sei Investments Co. increased its stake in Henry Schein by 8.0% in the 2nd quarter. Sei Investments Co. now owns 420,957 shares of the company’s stock valued at $26,983,000 after acquiring an additional 31,168 shares during the period. Pacer Advisors Inc. increased its stake in Henry Schein by 56.5% in the 2nd quarter. Pacer Advisors Inc. now owns 13,803 shares of the company’s stock valued at $885,000 after acquiring an additional 4,982 shares during the period. Sprucegrove Investment Management Ltd. increased its stake in Henry Schein by 1.3% in the 2nd quarter. Sprucegrove Investment Management Ltd. now owns 409,991 shares of the company’s stock valued at $26,280,000 after acquiring an additional 5,400 shares during the period. Finally, Simplify Asset Management Inc. increased its stake in Henry Schein by 5.0% in the 2nd quarter. Simplify Asset Management Inc. now owns 3,695 shares of the company’s stock valued at $237,000 after acquiring an additional 175 shares during the last quarter. 96.62% of the shares are held by hedge funds and other institutional investors.
Henry Schein Company Profile
(Get free report
Henry Schein, Inc. provides healthcare products and services to dentists, laboratories, physician offices, ambulatory surgery centers, government agencies, institutional health centers, and other alternative care settings worldwide. The company operates in two segments: Healthcare Delivery and Technology and Value-Added Services.
See also
Get daily news and reviews about Henry Schein – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Henry Schein and related companies with MarketBeat.com’s FREE daily email newsletter.
